PhRMA spent a record $27.5 million on lobbying in 2018 - STAT

PhRMA spent a record $27.5 million on lobbying in 2018 - STAT

PhRMA spent a record-breaking $27.5 million on lobbying in 2018

The drug industry’s most prominent lobbying group spent a record $27.5 million on lobbying activities in 2018. That’s far more than PhRMA’s previous record-setting spend in 2009, when it spent just over $25 million amid a heated debate over the Affordable Care Act in Congress. The group's 2018 spending is a sign of the threats that drug makers face in Washington, where lawmakers are ramping up their criticism of industry practices and the Trump administration escalates its efforts to bring drug prices down. More here.